Oil Prices Gain Slightly as OPEC+ Plan Disappoints

Jumat, 03 Juni 2022 | 14:57 WIB
Oil Prices Gain Slightly as OPEC+ Plan Disappoints
[ILUSTRASI. The sun sets behind a crude oil pump jack on a drill pad in the Permian Basin in Loving County, Texas, U.S. November 24, 2019. REUTERS/Angus Mordant/File Photo]
Reporter: Thomas Hadiwinata | Editor: Thomas Hadiwinata

KONTAN.CO.ID - MELBOURNE/SINGAPORE, June 3 (Reuters) - Oil prices edged higher on Friday as markets shrugged off the decision of OPEC+ to increase production and questioned whether the incremental output would make up for lost Russian supply and meet China's growing demand amid easing COVID restrictions.

U.S. West Texas Intermediate (WTI) crude CLc1 futures gained 7 cents to $116.94 a barrel at 0640 GMT, while Brent crude LCOc1 futures were up 18 cents at $117.79 a barrel.

A decision on Thursday by the Organization of the Petroleum Exporting Countries and allies, together called OPEC+, to boost output by 648,000 barrels per day (bpd) in July and August, instead of by 432,000 bpd as previously agreed, was seen as hardly enough for a tight market.

The increases were divided proportionally across the member countries, but with Russia included in the pact and members such as Angola and Nigeria already failing to meet their targets, analysts said the supply increase was likely to be less than the announced volume.

Baca Juga: Indonesia Raises 81 Billion Yen from Samurai Bond Sale

"The fact that Russia was left in the group suggests that production from the alliance will continue to struggle to meet even this modest increase in quota rises," ANZ Research analysts said in a note.

Russian output has already dropped by 1 million bpd since its invasion of Ukraine, which Moscow calls a "special military operation", and is likely to fall even further as the European Union's ban on Russian oil kicks in, ANZ analysts said.

"To put it another way, traders think the incremental increase is too small relative to the growing downside supply risks from the EU embargo amid an expected increased demand from China," said SPI Asset Management Managing Partner Stephen Innes.

With daily COVID-19 cases falling, China's financial hub Shanghai and capital, Beijing, have relaxed COVID-19 restrictions this week. The central Chinese government vowed broad support to stimulate the country's economy, which is expected to target high fuel intensity sectors such as infrastructure and property construction.

Baca Juga: Oil Prices Sit Tight as OPEC+ Plan Disappoints

Analysts warned, though, of downside risks to oil demand and prices, as Beijing has not changed its stance on COVID-19 rules.

"China’s re-opening from COVID lockdowns is positive for demand for now but the country retains a zero-COVID policy so snap lockdowns can quickly erode this impact," analysts from National Australia Bank said in a note.

Although Brent was on track to fall for the week, WTI was on course for its sixth weekly gain as U.S. supply is seen as very tight, prompting talk of fuel export curbs or a windfall profits tax on oil and gas producers.

Government data on Thursday showed U.S. crude stockpiles fell much more than expected in the week to May 27 and gasoline inventories fell, defying expectations for an increase.

Bagikan

Berita Terbaru

Strategi Investasi Aman Ala Direktur Sucorinvest, Jauh dari Volatilitas.
| Sabtu, 31 Januari 2026 | 06:15 WIB

Strategi Investasi Aman Ala Direktur Sucorinvest, Jauh dari Volatilitas.

Membeli saham big caps ternyata belum tentu untung. Direktur Sucorinvest Hermansyah bagikan strategi yang buat hidupnya tenang

Rupiah Terdampak Tekanan Keluar Dana Asing dari Bursa Saham
| Sabtu, 31 Januari 2026 | 06:00 WIB

Rupiah Terdampak Tekanan Keluar Dana Asing dari Bursa Saham

Rupiah melemah pada Jumat (30/1) namun menguat mingguan. Analis memperingatkan sentimen MSCI masih membayangi pergerakan rupiah

Multipolar Technology (MLPT) Memperluas Portofolio Solusi Digital
| Sabtu, 31 Januari 2026 | 05:25 WIB

Multipolar Technology (MLPT) Memperluas Portofolio Solusi Digital

Langkah ini sejalan dengan strategi MLPT untuk memperkuat posisi sebagai penyedia solusi transformasi digital end-to-end.

Menanti Tuah Jamsostek dkk Menjaga Bursa
| Sabtu, 31 Januari 2026 | 04:55 WIB

Menanti Tuah Jamsostek dkk Menjaga Bursa

BPJS Ketenagakerjaan punya rencana untuk terus meningkatkan alokasi investasi di instrumen saham sejak kuartal kedua tahun lalu.

Bundamedik (BMHS) Menjaga Kinerja Tetap Sehat
| Sabtu, 31 Januari 2026 | 04:20 WIB

Bundamedik (BMHS) Menjaga Kinerja Tetap Sehat

Industri kesehatan Indonesia bergerak ke fase yang semakin matang dan selektif dan tidak lagi semata didorong oleh ekspansi agresif.

Harga Perak Anjlok 13% Setelah Cetak Rekor, Aksi Ambil Untung Jadi Penyebab
| Jumat, 30 Januari 2026 | 22:29 WIB

Harga Perak Anjlok 13% Setelah Cetak Rekor, Aksi Ambil Untung Jadi Penyebab

Perak anjlok 13% setelah rekor, pertanda apa bagi investor? Aksi ambil untung masif memicu koreksi tajam. 

Petinggi BEI dan OJK Kompak Mundur Efek MSCI, ini Komentar Pengamat Hukum
| Jumat, 30 Januari 2026 | 21:46 WIB

Petinggi BEI dan OJK Kompak Mundur Efek MSCI, ini Komentar Pengamat Hukum

Pengunduran diri para petinggi BEI dan OJK tersebut terjadi di tengah upaya pembenahan struktural industri pasar modal nasional.

MSCI Effect, Pejabat Tinggi OJK dan BEI Kompak Mundur
| Jumat, 30 Januari 2026 | 19:29 WIB

MSCI Effect, Pejabat Tinggi OJK dan BEI Kompak Mundur

Pengumuman MSCI yang membekukan evaluasi indeks saham Indonesia hingga bulan Mei 2026, berbuntut panjang.

IHSG Masih Tertekan, Apakah Saham MBMA Masih Cukup Menarik?
| Jumat, 30 Januari 2026 | 16:19 WIB

IHSG Masih Tertekan, Apakah Saham MBMA Masih Cukup Menarik?

Perubahan lanskap geopolitik, hingga kebijakan energi berbagai negara menjadi faktor yang berpotensi menjaga momentum sektor komoditas.

Momen Ramadan Bisa Mendorong Kinerja Kalbe Farma (KLBF)
| Jumat, 30 Januari 2026 | 09:00 WIB

Momen Ramadan Bisa Mendorong Kinerja Kalbe Farma (KLBF)

Pertumbuhan laba PT Kalbe Farma Tbk (KLBF) di tahun ini akan didorong pemulihan pendapatan lintas segmen dan kontribusi bisnis obat resep.

INDEKS BERITA

Terpopuler